Searched for: All
A Win for Clinical Evidence: The First Head-to-Head Trial of Interventional Strategies for the Treatment of Pulmonary Embolism [Comment]
Rao, Sunil V; Gutierrez, J Antonio T
PMID: 39899637
ISSN: 1524-4539
CID: 5783752
Altered platelet phenotype in patients with type II endoleaks following abdominal aortic aneurysm repair
Pratama, Muhammad Yogi; King, Benjamin; Teter, Katherine A; Bi, Christina; Presedo, Natalie; Harish, Keerthi B; Giardinetto, Catarina Santos; Belleca, Sheehan; Chervonski, Ethan; Maldonado, Thomas S; Ramkhelawon, Bhama
BACKGROUND/UNASSIGNED:Endovascular abdominal aortic aneurysm repair (EVAR) is a preferred surgery to prevent aneurysm sac enlargement and minimize the risk of life-threatening rupture in patients with AAA. Serious complications of type II endoleaks following EVAR can cause sac expansion and increase rupture risk. This study focused on evaluating clinical and blood characteristics in patients with type II endoleaks to refine our understanding of systemic fluctuations associated with unsuccessful EVAR. METHODS/UNASSIGNED:This retrospective study included 146 patients with AAA who underwent primary elective endovascular procedures (EVAR/fEVAR) between 2013 and 2021. Clinical characteristics, complete blood count (CBC) and imaging data were analyzed from patients who did and did not develop type II endoleaks. RESULTS/UNASSIGNED:Mean platelet volume (MPV) was significantly increased in patients who developed type II endoleaks after EVAR. Receiver operating characteristic analysis showed that MPV has a satisfactory discriminatory performance in distinguishing post-EVAR patients who developed type II endoleaks, yielding an area under the curve (AUC) value of 0.64. A risk stratification panel incorporating MPV, type II diabetes history, and administration of dual antiplatelet therapies yielded an AUC of 0.70 and predicted an endoleak-free survival rate with a hazard ratio of 2.94. A nomogram revealed that MPV had the highest scoring weight among all significant variables. CONCLUSION/UNASSIGNED:Patients with type II endoleaks following EVAR have elevated MPV indicative of different phenotypes of circulating platelets. MPV presents an attractive predictive criteria for assessing the occurrence of type II endoleaks in patients with AAA.
PMID: 39625113
ISSN: 1477-0377
CID: 5783452
A Pilot Study: Evaluating Disposable Syringes Compared to Non-Disposable Syringes for Dental Training
Glickman, Robert; Byrd, Tara; Levine, Marci H; Sherwin, Gene; McAlpin, Elizabeth; Watson, Colleen; Soeprono, Aaron; Orthodoxou, Chrystalla; Couamin, Yvelande
BACKGROUND:Needlestick exposures commonly occur with non-disposable metal syringes during the assembly and disassembly of needles due to the manual handling of needles. Disposable syringes are designed to reduce these exposures by using a protective sheath thus eliminating the need to handle needles while uncapping and recapping them. PURPOSE/OBJECTIVE:This pilot study compared the two syringes with two alternating groups of third-year (D3) students during clinical practice under faculty supervision to administer local anesthesia to live patients. METHODS:In 2023, two groups of Year 3 (D3) Doctor of Dental Surgery (DDS) students supervised by faculty in each group alternated over two 4-week sessions using disposable (N = 67) and non-disposable (N = 66) syringes to administer local anesthesia injections to live patients. At the end of each session, each group and supervising faculty completed a survey to capture their experience. RESULTS:While two participants reported needlestick injuries using non-disposable syringes and no injuries incurred using disposable syringes, we found neither a statistically significant increase nor decrease in exposures related to needlesticks using either syringe. Statistically significant outcomes showed that the participants found the non-disposable easier to use and they were more likely to use it going forward than the disposable syringe. Participants preferred using the non-disposable syringe mainly because of the stability and familiarity aspects of prior education. The disposable syringe, while easier and safer to assemble and disassemble, felt less stable to use during the injection procedure, especially during aspiration. CONCLUSION/CONCLUSIONS:While safety continues to be a concern, students and faculty prefer non-disposable metal syringes over disposable syringes. Most dissatisfaction with using the disposable syringe came from the aspiration system. But prior experience and comfort using non-disposable metal syringes, a lack of experience and confidence with local anesthesia procedures and a lack of experience with disposable syringes, may have contributed to these outcomes. Despite usability issues with the disposable syringe, performance was more impacted by lack of experience than the type of syringe used. Introducing both syringes early into the curriculum may help overcome usability factors, further reduce needlestick exposures, and prepare students for different workplace environments. Providing adequate training for faculty, especially on the differences between the two syringes, such as aspiration, will help alleviate discomfort and better promote the use of both.
PMID: 39915946
ISSN: 1930-7837
CID: 5784512
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Hinz, Felix; Friedel, Dennis; Korshunov, Andrey; Ippen, Franziska M; Bogumil, Henri; Banan, Rouzbeh; Brandner, Sebastian; Hasselblatt, Martin; Boldt, Henning B; Dirse, Vaidas; Dohmen, Hildegard; Aronica, Eleonora; Brodhun, Michael; Broekman, Marike L D; Capper, David; Cherkezov, Asan; Deng, Maximilian Y; van Dis, Vera; Felsberg, Jörg; Frank, Stephan; French, Pim J; Gerlach, Rüdiger; Göbel, Kirsten; Goold, Eric; Hench, Jürgen; Kantelhardt, Sven; Kohlhof-Meinecke, Patricia; Krieg, Sandro; Mawrin, Christian; Morrison, Gillian; Mühlebner, Angelika; Ozduman, Koray; Pfister, Stefan M; Poliani, Pietro Luigi; Prinz, Marco; Reifenberger, Guido; Riemenschneider, Markus J; Sankowski, Roman; Schrimpf, Daniel; Sill, Martin; Snuderl, Matija; Verdijk, Robert M; Voisin, Mathew R; Wesseling, Pieter; Wick, Wolfgang; Reuss, David E; von Deimling, Andreas; Sahm, Felix; Maas, Sybren L N; Suwala, Abigail K
IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of brisk mitotic activity (grade 3) and necrosis and/or microvascular proliferation (grade 4). In addition, homozygous deletion of the CDKN2A/B locus has recently been implemented as a molecular marker for grade 4 IDH-mutant astrocytomas. Here, we describe a subgroup of high-grade IDH-mutant astrocytomas characterised by a primitive neuronal component based on histology and a distinct DNA methylation profile (n = 51, ASTRO PNC). Misinterpretation as carcinoma metastasis was common, since GFAP expression was absent in the primitive neuronal component, whereas TTF-1 expression was detected in 15/19 cases (79%) based on immunohistochemistry. Apart from mutations in IDH1, TP53, and ATRX, we observed enrichment for alterations in RB1 (n = 19/51, 37%) and MYCN (n = 14/51, 27%). Homozygous CDKN2A/B deletion (n = 1/51, 2%) and CDK4 amplification (n = 3/51, 6%) were relatively rare events. Clinical (n = 31 patients) and survival data (n = 23 patients) indicate a clinical behaviour similar to other CNS WHO grade 4 IDH-mutant astrocytomas, however with an increased risk for leptomeningeal (n = 7) and extra-axial (n = 2) spread. Taken together, ASTRO PNC is defined by a distinct molecular and histological appearance that can mimic metastatic disease and typically follows an aggressive clinical course.
PMCID:11790679
PMID: 39899075
ISSN: 1432-0533
CID: 5783712
Predictive models of post-prandial glucose response in persons with prediabetes and early onset type 2 diabetes: A pilot study
Santos-Báez, Leinys S; Diaz-Rizzolo, Diana A; Borhan, Rabiah; Popp, Collin J; Sordi-Guth, Ana; DeBonis, Danny; Manoogian, Emily N C; Panda, Satchidananda; Cheng, Bin; Laferrère, Blandine
OBJECTIVE:Post-prandial glucose response (PPGR) is a risk factor for cardiovascular disease. Meal carbohydrate content is an important predictor of PPGR, but dietary interventions to mitigate PPGR are not always successful. A personalized approach, considering behaviour and habitual pattern of glucose excursions assessed by continuous glucose monitor (CGM), may be more effective. RESEARCH DESIGN AND METHODS/METHODS:), with prediabetes (n = 35) or early onset type 2 diabetes (n = 3), together with sleep and physical activity by actigraphy. We assessed the predictive value of habitual CGM glucose excursions and fasting glucose on PPGR after a research meal (hereafter MEAL-PPGR) and during an oral glucose tolerance test (hereafter OGTT-PPGR). RESULTS:increase from 0.723 to 0.761). Neither anthropometrics, age nor habitual sleep and physical activity added to the prediction models significantly. CONCLUSION/CONCLUSIONS:These data support a CGM-guided personalized nutrition and medicine approach to control PPGR in older individuals with prediabetes and diet and/or metformin-treated type 2 diabetes.
PMCID:11802288
PMID: 39744832
ISSN: 1463-1326
CID: 5783472
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed
Block, Timothy M; Guo, Ju-Tao; Zoulim, Fabien; Rice, Charles M; Thio, Chloe L; Schneider, William M; Alter, Harvey J; Jacobson, Ira M; Gish, Robert G; Block, Peter D; Sulkowski, Mark; Feld, Jordan J; Cohen, Chari A
PMID: 39910374
ISSN: 1759-5053
CID: 5784152
Surgical Adverse Events for Primary Tumors of the Spine and Their Impact on Outcomes: An Observational Study From the Primary Tumors Research and Outcomes Network
Laflamme, Mathieu; Gasbarrini, Alessandro; Rhines, Laurence D; Lazary, Aron; Gokaslan, Ziya L; Reynolds, Jeremy J; Luzzati, Alessandro; Disch, Alexander C; Chou, Dean; Clarke, Michelle J; Wei, Feng; Bettegowda, Chetan; Rampersaud, Y Raja; Boriani, Stefano; Shin, John H; Lord, Elizabeth; Sciubba, Daniel M; Laufer, Ilya; Sahgal, Arjun; Fisher, Charles G; Dea, Nicolas; ,
BACKGROUND AND OBJECTIVES/OBJECTIVE:Aggressive resection for primary tumors of the spine are associated with a high rate of adverse events (AEs), but the impact of AEs on patient-reported outcomes (PROs) remains unknown and is critical to the shared decision-making. Our primary objective was to assess the impact of surgical AEs on PROs using an international registry. Assessing the impact on clinical outcomes and identifying risk factors for AEs were our secondary objectives. METHODS:Patients who underwent surgery for a primary spinal tumor were selected through the Primary Tumor Research and Outcomes Network. Our primary outcome was the impact of AEs on PROs at 3 and 12 months after surgery (measured with Spinal Oncology Study Group Outcomes Questionnaire, Short-Form 36, and EuroQol 5 Dimension). We also assessed the impact on clinical outcomes (local control, surgical margins, readmission, reoperation, and mortality). We stratified our results according to severity of AEs, histology, and type of resection. RESULTS:374 patients met inclusion criteria (219 males/155 females). The mean age of the cohort was 48.7 years. The most frequent histology was chordoma (37.3%) followed by chondrosarcoma (8.8%). Sixty-seven patients (17.9%) experienced at least 1 intraoperative AE and 117 patients (31.3%) had at least 1 postoperative AE within 3 months. Overall, 159 patients (42.5%) experienced AEs. The readmission rate was significantly higher in patients who experienced AEs (Any AE: 10.1% vs no AE: 1.9% within 3 months; P = <0.001). PROs were not significantly affected by AEs in most questionnaires. Local control, risk of reoperation, mortality, and achieving preplanned margins were similar between AE groups. CONCLUSION/CONCLUSIONS:The rate of surgical AEs is considerable in this population. Surgical AEs seem to be associated with a higher number of readmissions, but do not seem to result in significant differences in PROs or in a higher risk of reoperation, mortality, and failure to achieve preplanned margins.
PMID: 39907438
ISSN: 1524-4040
CID: 5783952
Monoamine neurochemistry, behavior, and microhabitat contribute to male coquí frog modes: silent, territorial, and paternal
Eyck, Gary R Ten; Regen, Erin M; Ten Eyck, Sarah E; Korzan, Wayne J; Summers, Cliff H
Monoaminergic neurotransmitters are essential for a multitude of physiological and behavioral functions including territoriality and parental care. The Puerto Rican coquí frog, Eleutherodactylus coqui, possesses an intriguing multi-modal male behavioral organization whereby males can be territorial, paternal, and silent (non-calling). The objective of this study was to quantify central monoamines in the three male modes and integrate this neurochemistry with data from microhabitat shelter selection and male social structure. Males were assessed for monoamines and metabolites using high performance liquid chromatography with electrochemical detection. Results indicated that there are distinct and significant differences among the three male behavioral modes based on male social structure, microhabitat shelter selection, and neurochemistry. Silent males are non-combative, quiescent, occur nocturnally in relatively open locations with sparser vegetation, and are characterized by high levels of epinephrine and norepinephrine in several forebrain nuclei. Territorial males emit vocalizations, are typically surrounded by more vegetation than silent males, may have a silent male within their territory, and are denoted by significantly higher levels of norepinephrine in the preoptic area and ventral hypothalamus and dopamine in the amygdala responsible male territorial behaviors. Paternal males brood and guard developing embryos in secluded nest sites that are surrounded by vegetation, not within territories of residential males, and typically not in close proximity of silent males. Paternal brains have significantly higher levels epinephrine and serotonin in the raphe and reticular nuclei indicating the necessity to regulate metabolic processes and stress during the period of prolong paternal care.
PMID: 39909908
ISSN: 1432-1351
CID: 5784132
Biological Markers in the Gingival Crevicular Fluid Associated with External Invasive Resorption: A Split-Mouth Cross-Sectional Study
Malek, Matthew; Steff, Laura; Vakil, Nikita; Jothilingam, Rathimala; Huh, Sunna; Chien, Tiffany; Halpern, Rachel; Gencerliler, Nihan; Erdoğan, Ozge; Songtrakul, Kamolthip
INTRODUCTION/BACKGROUND:This study aimed to investigate the levels of interleukin-1 receptor antagonist (IL-1RA), receptor activator of nuclear factor-κB ligand (RANKL), osteoprotegerin (OPG), interleukin-1β, osteopontin, and tissue necrotizing factor-α in teeth with external invasive resorption (EIR) in comparison to the contralateral healthy tooth of the same patient. METHODS:Twenty-nine patients with at least one tooth with EIR and a healthy tooth on the contralateral side (33 paired teeth) were included. Data on patient demographics and medical and dental history were collected. Gingival crevicular fluid was collected from the subject and control teeth. Clinical, radiographical, and cone-beam computed tomography examinations were performed. Wilcoxon signed-rank test was used to compare biomarker concentrations, RANKL/OPG, and IL-1RA/interleukin-1β ratios in the diseased and healthy teeth. Teeth pairs were grouped based on Heithersay and Patel's classification, and the differences in biomarker concentrations between diseased and healthy teeth were compared using a Kruskal-Wallis test. RESULTS:Teeth with EIR had significantly lower concentrations of IL-1RA and OPG compared to their respective healthy control teeth (P < .05). The RANKL/OPG ratio in teeth with EIR was significantly higher than in their paired healthy teeth (P < .05). A history of herpes zoster infection was associated with a higher IL-1RA concentration and RANKL/OPG ratio (P < .05). Orthodontic treatment was significantly associated with lower OPG concentration (P < .05). CONCLUSIONS:There is a significant association between EIR and specific biological markers. A history of orthodontic treatment and herpes zoster infection are significantly associated with altered levels of biomarkers in the gingival crevicular fluid.
PMID: 39617293
ISSN: 1878-3554
CID: 5784472
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS study
Usmani, Saad Z; Facon, Thierry; Hungria, Vania; Bahlis, Nizar J; Venner, Christopher P; Braunstein, Marc; Pour, Ludek; Martí, Josep M; Basu, Supratik; Cohen, Yael C; Matsumoto, Morio; Suzuki, Kenshi; Hulin, Cyrille; Grosicki, Sebastian; Legiec, Wojciech; Beksac, Meral; Maiolino, Angelo; Takamatsu, Hiroyuki; Perrot, Aurore; Turgut, Mehmet; Ahmadi, Tahamtan; Liu, Weiping; Wang, Jianping; Chastain, Katherine; Vermeulen, Jessica; Krevvata, Maria; Lopez-Masi, Lorena; Carey, Jodi; Rowe, Melissa; Carson, Robin; Zweegman, Sonja
Frontline daratumumab-based triplet and quadruplet standard-of-care regimens have demonstrated improved survival outcomes in newly diagnosed multiple myeloma (NDMM). For patients with transplant-ineligible NDMM, triplet therapy with either daratumumab plus lenalidomide and dexamethasone (D-Rd) or bortezomib, lenalidomide and dexamethasone (VRd) is the current standard of care. This phase 3 trial evaluated subcutaneous daratumumab plus VRd (D-VRd) in patients with transplant-ineligible NDMM or for whom transplant was not planned as the initial therapy (transplant deferred). Some 395 patients with transplant-ineligible or transplant-deferred NDMM were randomly assigned to eight cycles of D-VRd or VRd followed by D-Rd or Rd until progression. The primary endpoint was overall minimal residual disease (MRD)-negativity rate at 10-
PMID: 39910273
ISSN: 1546-170x
CID: 5784142